Skip to main content
OpenTrials
Completed

NCT Number: NCT03489213

Nutrition and Exercise Trial: Improving Diet and Physical Activity Patterns in Overweight Cancer Survivors

This randomized phase II trial will enroll overweight cancer survivors. Subjects in both groups will be educated to follow a diet pattern similar to what is recommended by the Dietary Guidelines for Americans and the American Institute for Cancer Research (DGA/AICR) but one group will also receive 18 ounces of lean beef for incorporation into a healthy diet. Subjects will be encouraged to exercise regularly and activity will be monitored throughout the study. Nutrition and exercise may help cancer survivors successfully maintain improved dietary patterns, body composition, and physical activity efforts and consumption of beef may favorably impact lean body mass and specific nutritional outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

About this study

PRIMARY OBJECTIVES:

I. To determine the feasibility and compliance with a the Dietary Guidelines for Americans/American Institute for Cancer Research (DGA/AICR) healthy dietary pattern and a beef + DGA/AICR healthy dietary pattern in cancer survivors.

II. To determine the impact of dietary interventions on body composition, clinical outcomes, and physical performance.

III. To quantify the impact of the two dietary interventions on cardiometabolic biomarkers of health.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive DGA/AICR-based dietary intervention for 6 months consisting of 12 education sessions over 60 minutes every other week, fruit, vegetable, and herb harvesting 1-2 times per week for 2 hours, wearing a FitBit during physical activity, and remote health coaching over 10 minutes for 12 weeks.

ARM II: Patients receive DGA/AICR-based dietary intervention as in Arm I and consume 11-18 ounces of lean beef each week for 6 months.

Clinical and physical activity assessments will take place at baseline, after the intervention and at 12 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Have a body mass index (BMI) >= 25 kg/m^2
  • Be non-vegetarian/non-vegan, and have no concerns with beef consumption
  • Have completed active curative therapy for cancer within the past 36 months (i.e., surgery, chemotherapy, or radiation); ongoing hormone therapy is acceptable
  • Voluntarily provide consent, Health Insurance Portability and Accountability Act (HIPPA) authorization form, and consent from primary care provider (PCP) or treating oncologist
  • Not be planning to travel for more than 3 consecutive weeks during the intervention period
  • Agree to refrain from all nutritional supplements, herbal supplements, and botanical supplements aside from those prescribed by a physician for the duration of the study

Exclusion criteria

  • Are cognitively unable to consent or have physical or mental limitations that would prevent full participation in the program
  • Are vegan or those unwilling to consume 11-18 ounces (oz) of beef per week
  • Have pre-existing medical conditions that preclude unsupervised physical activity (i.e., severe orthopedic conditions, impending hip or knee replacement, paralysis, unstable angina, dementia, recent history of myocardial infarction, congestive heart failure, pulmonary conditions requiring oxygen, or hospitalization in past 6 months)
  • Have had cancer treatment that significantly impacts digestion, metabolism, or food intake (e.g., surgical loss of esophagus, stomach, or colon, pancreas dysfunction, or brain surgery that alters cognition, etc.)
  • Report meeting the recommendations for physical activity (> 60 minutes per day, most days per week) and already meet the majority of dietary guidelines as assessed by a telephone screener
  • Are prescribed medication that do not allow for increased intake of fruits and vegetables
  • Have recently (< 3 months) started a statin or other lipid lowering medication; participants who report that they are changing a lipid lowering drug dose or drug type during the recruitment period will also be excluded; participants who have been stable on a lipid-lowering medication for at least 3 months may participate; well-controlled diabetics (type I or II) may participate
  • Have been diagnosed with active metabolic or digestive illnesses (i.e., Celiac disease, irritable bowel syndrome [IBS], renal insufficiency, hepatic insufficiency)
  • Are pregnant or are planning to become pregnant during the study

Treatment and study plan

Dietary Intervention

Other

Participants randomized to the DGA/AICR group will receive plant-based diet education, garden access and health coaching for 5 months. The sessions are offered every other week.

Other names: Dietary Modification, intervention, dietary, Nutrition Intervention, Nutrition Interventions, Nutritional Interventions

Exercise Intervention

Behavioral

Participants will wear a FitBit every day and monitor daily physical activity.

laboratory biomarker analysis

Other

Correlative studies

Nutritional intervention

Dietary Supplement

Participants randomized to the beef group will receive 11 to 18 ounces of frozen lean beef each week for home preparation, in addition to DGA/AICR diet education, garden access and health coaching.

Questionnaire Administration

Other

Ancillary studies

Primary outcomes

  1. Adherence to either the DGA/AICR group or the DGA/AICR + Beef group

    Time frame: Up to 12 months

    Participants will keep both 7 day diet records periodically through out the study as well as a daily log of beef consumption

  2. Change in body composition

    Time frame: Up to 12 months

    Change in body composition will be assessed by dual X-ray absorptiometry (iDXA)

  3. Change in blood pressure

    Time frame: Baseline up to 12 months

    Trained personnel will use a sphygomanometer to assess blood pressure

  4. Change in body mass index (BMI)

    Time frame: Baseline up to 12 months

    Weight and height will be combined to report BMI in kg/m^2.

  5. Change in dietary carotenoid intake

    Time frame: Baseline up to 12 months

    Assessed by Raman spectroscopy

  6. Change in blood carotenoids

    Time frame: Up to 12 months

    Assessed by High Pressure Liquid Chromatography

  7. Change in physical performance assessed by timed performance-related mobility tasks

    Time frame: Baseline up to 12 months

    Physical performance will be measured using the 40 M walk test

  8. Change in physical performance

    Time frame: Up to 12 months

    Assessed by a standardized stair climb test

  9. Dietary intake patterns

    Time frame: Up to 6 months

    Will be assessed using diet logs maintained throughout the intervention and graphical food frequency questionnaire (FFQ). This FFQ automatically calculates the Healthy Eating Index 2010. Will use previous 30-day intake for all FFQs to assess dietary patterns. To determine protein balance, will use a 7-day diet record prior to a 24-hr urine collection.

  10. Adherence to classes

    Time frame: Up to 12 months

    Descriptive statistics will be generated using attendance forms

  11. Change in fasting glucose

    Time frame: Up to 12 months

    A fasting blood sample will be used to measure glucose at three time points

  12. Change in lipoprotein profiles

    Time frame: Up to 12 months

    A fasting blood sample will be used to assess serum lipoprotein profile

  13. Daily physical activity (steps per day)

    Time frame: up to 12 months

    Each participants daily FitBit data will be downloaded to a secure spreadsheet

Secondary outcomes

  1. Health related quality of life

    Time frame: Up to 12 months

    Measured at all three time points using the Health Related Quality of Life (HR-QOL) questionnaire

Sponsors and collaborators

Lead sponsor

Ohio State University Comprehensive Cancer Center

Other

Registry information

Official study title

NExT (Nutrition and Exercise Cancer Survivor Trial)

Acronym: NExT

Important dates

Study start
2017
Primary completion
2018
Study completion
2019
First posted
Apr 5, 2018
Registry last updated
Aug 30, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.